The use of transgenic murine models such as IL‐22, IL‐17, and RORγt‐deficient mice57, 58, 59 will help to delineate the role of Th17‐like hILC1s in bladder cancer. The gene discussed is IL17A; the disease is urinary bladder carcinoma.